Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday,...
-
Enabling high densities needed for discrete chips using standard materials and toolsSelector technology also suitable for the embedded market, a significant step forward for edge AI and automotive...
-
Highlights: Immuron has signed a subscription and option agreement with leading gut health biotech Ateria Health: Strategic investment of approximately £1.5m (A$2.6m) to acquire an initial 17.5% of...
-
VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Highlights Significant Intercepts Continued wide and high-grade drill intercepts returned from the CV5 Pegmatite...
-
Perth, Oct. 12, 2022 (GLOBE NEWSWIRE) -- QUARTERLY REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/October 12, 2022/Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and...
-
No lost-time injuries recorded during Q3 2022 or year-to-date 2022Q3 2022 production of 13,137 oz Au, exceeding operational wind-down guidance1, bringing total production for year-to-date 2022 to...
-
BRISBANE, Australia, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Allkem Limited (ASX|TSX: AKE) (“Allkem” or “the Company”) will release its September Quarter Activities Report on Friday, 21 October 2022. ...
-
BRISBANE, Australia, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Allkem Limited (ASX|TSX: AKE, “Allkem” or the “Company”) and the International Finance Corporation (“IFC”) have agreed on a non-binding term...
-
VANCOUVER, British Columbia, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Patriot Battery Metals Inc. (the “Company” or “Patriot”) (TSXV: PMET) (OTCQB: PMETF) (FSE: R9GA) is pleased to announce that it has...
-
SYDNEY, AUSTRALIA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel immunotherapies...